NCT02223117View on ClinicalTrials.gov

Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes® in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

July 21, 2016

Study Completion Date

July 21, 2016

Conditions
Healthy
Interventions
BIOLOGICAL

Thrombosomes

Freeze-dried platelets

BIOLOGICAL

Placebo

Trial Locations (1)

98104

Bloodworks Northwest, Seattle

Sponsors
All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Cellphire Therapeutics, Inc.

INDUSTRY